Can I read Formulation And Evaluation Of Cosmetic Foundation Using Epigallocatechin Gallate As A Sun Protection on EtoBox?

Formulation And Evaluation Of Cosmetic Foundation Using Epigallocatechin Gallate As A Sun Protection by ANWAR, EFFIONORA; RIZKAMIARTY, SHIFA is a Pharmacology, Toxicology and Pharmaceutics article available to read on EtoBox.

What is Formulation And Evaluation Of Cosmetic Foundation Using Epigallocatechin Gallate As A Sun Protection about?

Objective: The objective of the study was to obtain a lotion foundation using epigallocatechin gallate (EGCG) as an active ingredient designed with asun protection factor (SPF) value around 30 that can effectively protect facial skin from ultraviolet radiation (UVR) exposure and that is safe to use.Methods: In this study, we determine SPF value using UV–visible spectrophotometry at a wavelength between 290 and 320 nm. The preparationformula of the foundation was made with an EGCG concentration of 0.4%, a concentration which can yield the desired SPF value of about 30. Physicalstability was performed at low (4±2°C), ambient (25±2°C), and high (40±2°C) temperatures; cycling and centrifugation tests were also conducted.Safety was evaluated by eye irritation test using hen’s egg test on chorioallantois method and skin irritation test using the Draize and patch testsmethod.Results: The SPF values of 0.04% EGCG and lotion foundation containing 0.4% EGCG were 31.02±0.72 and 33.20±0.59, respectively. The results ofcycling and centrifugal tests indicated that lotion foundation showed an absence of crystals and lack of any phase separation between oil and waterphases. The physical stability

Who reads Formulation And Evaluation Of Cosmetic Foundation Using Epigallocatechin Gallate As A Sun Protection?

Author

ANWAR, EFFIONORA; RIZKAMIARTY, SHIFA

Publisher

Innovare Academic Sciences; International Journal of Applied Pharmaceutics; Sagar: Avijeet Jain; Innovare Academic Sciences Pvt Ltd (ISSN 0975-7058)

Published

2020

Language

EN

Field

Pharmacology, Toxicology and Pharmaceutics (Life Sciences)